U.S. Markets close in 3 hrs 48 mins

Juniper Wins New Deal

Zacks Equity Research

More deals are flowing for the networking company Juniper Networks (JNPR). Recently, Availity has opted for Juniper’s data center switching, WAN routing and security solutions to improve its national health information network across numerous data centers. This will help Availity to scale more than two billion health care business transactions annually.

Cloud computing on the whole is turning out to be a big positive for Juniper. Juniper also made significant additions to the Juniper Networks vGW Virtual Gateway solution for customers looking for a comprehensive virtualization security platform.

These functions are offered along with virtualization-specific antivirus (AV) to secure and continuously monitor malware and hackers, at the same time ensuring that security does not impede virtualized workload performance or form a barrier to implementing large-scale virtualized environments.

Juniper delivered decent third quarter 2012 results by beating the Zacks Consensus Estimates both on the top and bottom lines. However, year over year comparisons were not much encouraging. Cash position improved, while debt remained constant. Growth in operating expenses was aided by one-time items. Moreover, the company has also made provisions for a tightly-integrated virtual solution for defense-in-depth protection and centralized security management. This will help it to cater to different security agencies.

We are positive about Juniper’s new product traction, focus on revenue growth, cost reduction initiatives, improving supply chain and procurement activities. Despite stiff competition from F5 Networks Inc.(FFIV) and Cisco Systems Inc. (CSCO) we believe that Juniper is well-positioned in the networking space and can capitalize on the worldwide spending on information technology.

The company has a Zacks #2 Rank (Buy).

Read the Full Research Report on CSCO

Read the Full Research Report on JNPR

Read the Full Research Report on FFIV

Zacks Investment Research

More From Zacks.com